{
    "medicine_id": "f71a3460c4b640db9ff79559c9aaf1c6c74bd01c",
    "platform_id": "DB14914",
    "metadata": {
        "name": "Tauvid 51 mCi 1mL Injection solution",
        "composition": "51 mCi 1mL Flortaucipir F 18",
        "clinical_particulars": {
            "therapeutic_indications": "Flortaucipir F 18 is a radioactive agent indicated for positron emission tomography PET imaging of aggregated tau neurofibrillary tangles NFTs in adult patients under evaluation for Alzheimer s disease Flortaucipir F 18 is not indicated for use in patients under evaluation for chronic traumatic encephalopathy L14114",
            "contraindications": {
                "disease": "Toxicity information regarding Flortaucipir F 18 is not readily available Patients experiencing an overdose are at an increased risk of severe adverse effects such as headaches and increased blood pressure Symptomatic and supportive measures are recommended",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Flortaucipir F 18 is a radioactive molecule that binds to and accumulates in tau NFT deposits allowing for imaging detection however non specific binding and other factors allow for the possibility of misdiagnosis As Flortaucipir F 18 is a radioactive substance standard precautionary measures for protecting both patients and health care workers are advised The safety and efficacy of flortaucipir F 18 in patients being evaluated for chronic traumatic encephalopathy are unknown and hence is not recommended L14114",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}